0 NASDAQ Companies - August 11, 2020Open Lending Reports Second Quarter 2020 Financial ResultsAUSTIN, Texas, Aug. 11, 2020 (GLOBE NEWSWIRE) — Open Lending Corporation (NASDAQ: LPRO) (the “Company” or “Open Lending”), a leading […]Read More
0 NASDAQ Companies - August 11, 2020ADDvantage Technologies Reports Financial Results for Third Quarter of Fiscal 2020CARROLLTON, Texas, Aug. 11, 2020 (GLOBE NEWSWIRE) — ADDvantage Technologies Group, Inc. (NASDAQ: AEY) (“ADDvantage Technologies” or the “Company”) today […]Read More
0 NASDAQ Companies - August 11, 2020VirTra Reports Second Quarter and Six Month 2020 Financial ResultsTEMPE, Ariz., Aug. 11, 2020 (GLOBE NEWSWIRE) — VirTra, Inc. (NASDAQ: VTSI) (“VirTra”), a global provider of training simulators for the […]Read More
0 NASDAQ Companies - August 11, 2020Health Catalyst Reports Second Quarter 2020 ResultsSALT LAKE CITY, Aug. 11, 2020 (GLOBE NEWSWIRE) — Health Catalyst, Inc. (Nasdaq: HCAT), a leading provider of data and […]Read More
0 NASDAQ Companies - August 11, 2020Pacific Ethanol Reports Second Quarter 2020 ResultsNet income of $14.6 million and Adjusted EBITDA of $28.8 millionAdjusted EBITDA for the second half of 2020 expected to […]Read More
0 NASDAQ Companies - August 11, 2020Kornit Digital Reports Second Quarter 2020 ResultsAnnounces Acquisition of Custom Gateway, a leading global provider of cloud software workflow solutions enabling on-demand apparel and home décor […]Read More
0 NASDAQ Companies - August 11, 2020SeaSpine® Announces Limited Commercial Launch of Explorer™ TO Expandable Interbody DeviceCARLSBAD, Calif., Aug. 11, 2020 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on […]Read More
0 NASDAQ Companies - August 11, 2020T2 Biosystems Announces Second Quarter 2020 Financial ResultsLEXINGTON, Mass., Aug. 11, 2020 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, […]Read More
0 NASDAQ Companies - August 11, 2020Alector Reports Second Quarter 2020 Financial Results and Provides Corporate UpdatePivotal Phase 3 trial of AL001 initiated for treatment of frontotemporal dementia due to a progranulin gene mutation (FTD-GRN)Promising preliminary […]Read More
0 NASDAQ Companies - August 11, 2020Motus GI Reports Second Quarter 2020 Financial Results and Provides Corporate UpdateThe Pure-Vu® System launched in more than 20 major U.S. hospitals, with new evaluations added during the quarter The Pure-Vu® System […]Read More